Seroprevalence of Human Herpesvirus-8 in Blood Donors From Different Geographical Regions of Argentina, Brazil, and Chile
Author
dc.contributor.author
Pérez, Celeste
Author
dc.contributor.author
Tous, Mónica
es_CL
Author
dc.contributor.author
Gallego, Sandra
es_CL
Author
dc.contributor.author
Zala, Norma
es_CL
Author
dc.contributor.author
Rabinovich, Óscar
es_CL
Author
dc.contributor.author
Garbiero, Susana
es_CL
Author
dc.contributor.author
Martínez Galofre, María José
es_CL
Author
dc.contributor.author
Gusmao Cunha, Andrea Mendonca
es_CL
Author
dc.contributor.author
Camino, Sofía
es_CL
Author
dc.contributor.author
Cámara, Alicia
es_CL
Author
dc.contributor.author
Botelho Costa, Sandra Cecilia
es_CL
Author
dc.contributor.author
Larrondo, Milton
es_CL
Author
dc.contributor.author
Francalancia, Verónica
es_CL
Author
dc.contributor.author
Landreau, Fernando
es_CL
Author
dc.contributor.author
Bartomioli, Miguel Angel
es_CL
Admission date
dc.date.accessioned
2014-01-09T17:31:47Z
Available date
dc.date.available
2014-01-09T17:31:47Z
Publication date
dc.date.issued
2004
Cita de ítem
dc.identifier.citation
Journal of Medical Virology 72:661–667 (2004)
en_US
Identifier
dc.identifier.other
DOI 10.1002/jmv.20029
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/129120
General note
dc.description
Artículo de publicación ISI
en_US
Abstract
dc.description.abstract
Human herpesvirus-8 (HHV-8) causes Kaposi’s
sarcoma (KS) and lymphoproliferative disorders
in both HIV-infected and uninfected patients.
HHV-8 has a worldwide occurrence but infection
rates vary according to a combination of geographic
and behavioral risks. The main transmission
route seems to be sexual, nevertheless,
nasal secretions, saliva, blood, and organ graft
have been proposed. HHV-8 was postulated as a
new infectious agent for screening in blood
donors. The aim of this study was to evaluate
the prevalence of antibodies against HHV-8
antigens in blood donors of South America.
Serum samples from 2,470 blood donors from
Argentina, Brazil, and Chile corresponding to five
geographic regions were studied by indirect
immunofluorescence assay (IFA). Seroprevalence
rate was 3.7% (92/2,470; 95% CI 2.9–4.5) in
the entire blood donor population distributed
as follows: Argentina, 4.0% (Buenos Aires city,
4.3%; Bahia Blanca, 2.4%; and Co´ rdoba, 4.0%),
Campinas (Brazil), 2.8%; and Santiago de Chile,
3.0%. There was no difference (P>0.05) between
men and women or age related, except in Brazil
where positive cases were 30–49-year-old males.
The present study, which includes different
geographical areas of multiple countries from
South America, has not been done before. The
results show similar prevalence rates among the
studied zones corresponding to low-prevalence
regions. South America is a large sub-continent
with a wide spectrum of population and geographical
characteristics, thus, more HHV-8 prevalence
studies should be necessary to establish
possible regional differences.